Recent Finacing
Recent Raise
Neukio Biotherapeutics develops and commercializes iPSC-derived off-the-shelf CAR-NK allogeneic cell therapies for solid tumors, building scalable in-house manufacturing, R&D pipelines, and academic-industrial collaborations.
